William D. Clark's most recent trade in Aldeyra Therapeutics Inc was a trade of 70,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aldeyra Therapeutics Inc | William D. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2026 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | William D. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2026 | 2,323 | 2,323 | - | - | Stock Option (Right to Buy) | |
| iBio Inc | William D. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 13,500 | 13,500 | - | - | Stock Option (right to buy) | |
| Aldeyra Therapeutics Inc | William D. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2025 | 76,760 | 76,760 | - | - | Stock Option (Right to Buy) | |
| iBio Inc | William D. Clark | Director | Purchase of securities on an exchange or from another person at price $ 2.72 per share. | 10 Jan 2025 | 1,838 | 1,838 (0%) | 0% | 2.7 | 4,999 | Common Stock |